ExodusPoint Capital Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

ExodusPoint Capital Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,958	Closed	-$201K	–	2187
2023 Q3	$201K	Buy	+10,958	New	+$229K	﹤0.01%	1524
2022 Q3	–	Sell	-67,233	Closed	-$763K	–	2517
2022 Q2	$763K	Buy	+67,233	New	+$989K	0.01%	1191
2020 Q4	–	Sell	-14,115	Closed	-$254K	–	2599
2020 Q3	$254K	Buy	+14,115	New	+$256K	0.01%	1368

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ExodusPoint Capital Management's INBX Position: Q4 2023 in Review

ExodusPoint Capital Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q4 2023, closing a stake of 10,958 shares — an estimated $201K sold.

ExodusPoint Capital Management first reported a position in INBX in Q3 2020 and held it in 3 quarters. The position peaked at $763K in Q2 2022. 127 funds tracked by Wall St. Rank hold INBX as of Q4 2023.

ExodusPoint Capital Management reported no remaining Inhibrx, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 10,958 Inhibrx, Inc. Common Stock shares in Q4 2023, an estimated $201K.
ExodusPoint Capital Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
ExodusPoint Capital Management's Inhibrx, Inc. Common Stock position peaked at $763K in Q2 2022.
127 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.